Literature DB >> 18180122

Anti-inflammatory activity of arctigenin from Forsythiae Fructus.

Hyo Sook Kang1, Ji Yun Lee, Chang Jong Kim.   

Abstract

Oleaceae Forsythiae Fructus has been used for anti-inflammatory, diuretics, antidote, and antibacterials in traditional herbal medicine. Our previous screening of medicinal plants showed that methanol (MeOH) extract of Forsythiae Fructus had significant anti-inflammatory activity, but the active ingredients remain unclear. For isolation of active ingredient of MeOH extract of Forsythiae Fructus, it was partitioned with n-hexane and ethylacetate (EtOAc), and arctigenin was isolated from EtOAc fraction by column chromatography with anti-inflammatory activity-guided separation. Its activity was evaluated in the animal models of inflammation including myeloperoxidase (MPO) and eosinophil peroxidase (EPO) activities in the edematous tissues homogenate, and silica-induced reactive oxygen species (ROS) production in the RAW 264.7 cell line. It was shown that arctigenin (100 mg/kg) had significantly decreased not only carrageenan-induced paw edema 3 and 4h after injection of carrageenan, arachidonic acid (AA)-induced ear edema at a painting dose of 0.1-1.0mg/ear, and acetic acid-induced writhing response and acetic acid-induced capillary permeability accentuation at an oral dose of 25-100, and 100 mg/kg, respectively, but also MPO and EPO activities at a painting dose of 0.1-1.0mg/ear in the AA-induced edematous tissues homogenate as indicators of neutrophils and eosinophils recruitment into the inflamed tissue. Further, arctigenin (0.1-10 microM) also significantly inhibited the intracellular ROS production by silica. These results indicate that arctigenin is a bioactive agent of Forsythiae Fructus having significant anti-inflammatory action by inhibition of the exudation, and leukocytes recruitment into the inflamed tissues. The pharmacologic mechanism of action of arctigenin may be due to the inhibition of release/production of inflammatory mediators such as AA metabolites and free radicals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18180122     DOI: 10.1016/j.jep.2007.11.030

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  34 in total

1.  Quality means decency-on the quality of teaching through accreditation of the course?

Authors:  Bernd Markert; Bernd Delakowitz; Stefan Fränzle; Simone Wünschmann
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-24       Impact factor: 4.223

2.  Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways.

Authors:  Ruo-ming Wu; Yan-yan Sun; Ting-ting Zhou; Zhi-yuan Zhu; Jing-jing Zhuang; Xuan Tang; Jing Chen; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

3.  Determination of phillygenin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.

Authors:  Liang-hong Ye; Yun-xia Li; Cheng Peng; Xiao-hong Gong; Xin-guang Zheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-07       Impact factor: 2.441

4.  Comparative transcriptome analyses of three medicinal Forsythia species and prediction of candidate genes involved in secondary metabolisms.

Authors:  Luchao Sun; Amit Rai; Megha Rai; Michimi Nakamura; Noriaki Kawano; Kayo Yoshimatsu; Hideyuki Suzuki; Nobuo Kawahara; Kazuki Saito; Mami Yamazaki
Journal:  J Nat Med       Date:  2018-05-07       Impact factor: 2.343

5.  Gastroprotective effects of arctigenin of Arctium lappa L. on a rat model of gastric ulcers.

Authors:  Xiao-Mei Li; Yu Miao; Qin-Yong Su; Jing-Chun Yao; Hong-Hua Li; Gui-Min Zhang
Journal:  Biomed Rep       Date:  2016-10-04

Review 6.  Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L.

Authors:  Qiong Gao; Mengbi Yang; Zhong Zuo
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

7.  Anti-inflammatory and analgesic effects of Bi-yuan-ling granules.

Authors:  Xiao-Bing Chen; Han-Wen Su; Huan-Xiang Liu; Xian Yin; Feng He; Yong-Shen Ren; Kang Dai; Mei-Xian Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

8.  Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.

Authors:  Wen Li; Zhihui Zhang; Kai Zhang; Zhenyi Xue; Yan Li; Zimu Zhang; Lijuan Zhang; Chao Gu; Qi Zhang; Junwei Hao; Yurong Da; Zhi Yao; Ying Kong; Rongxin Zhang
Journal:  Mol Neurobiol       Date:  2015-10-06       Impact factor: 5.590

9.  Arctigenin Confers Neuroprotection Against Mechanical Trauma Injury in Human Neuroblastoma SH-SY5Y Cells by Regulating miRNA-16 and miRNA-199a Expression to Alleviate Inflammation.

Authors:  Jie Song; Na Li; Yang Xia; Zhong Gao; Sa-Feng Zou; Yu-Hui Yan; Shao-Heng Li; Yue Wang; Ya-Kun Meng; Jing-Xian Yang; Ting-Guo Kang
Journal:  J Mol Neurosci       Date:  2016-07-07       Impact factor: 3.444

10.  Arctigenin from Arctium lappa inhibits interleukin-2 and interferon gene expression in primary human T lymphocytes.

Authors:  Wei-Jern Tsai; Chu-Ting Chang; Guei-Jane Wang; Tzong-Huei Lee; Shwu-Fen Chang; Shao-Chun Lu; Yuh-Chi Kuo
Journal:  Chin Med       Date:  2011-03-25       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.